Researchers are calling for mandatory guidelines after a global review found massive inconsistencies in how "silent trials" are used to test medical AI tools in clinical settings.
Most Recent Articles
Developmental Reprogramming of Melanocortin Neurons and Obesity Susceptibility
A newly discovered genetic switch in the brain's hypothalamus determines lifelong appetite levels and can be manipulated to protect against obesity, according to UT Southwestern researchers.
Resident Cardiac Macrophages and Fibroblasts: A New Target for AF Maintenance
New research shows that resident heart macrophages and fibroblasts create specialized "driver regions" that help sustain persistent atrial fibrillation, offering a new target for personalized ablation therapy
Reducing Localization Error in Electrophysiology via Global Volumetric Mapping
New volumetric mapping technology allows doctors to see inside the heart walls non-invasively, reducing arrhythmia localization errors by nearly 60% to improve cardiac ablation accuracy.
Optimizing Structural Heart Disease Screening via Longitudinal EHR Pattern Recognition
The new TARGET-AI framework helps clinicians decide exactly when to use AI heart screening tools by analyzing patient records to predict who will benefit most from advanced testing.